Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2300039	恩曲他滨丙酚替诺福韦片(Ⅱ)	emtricitabine;tenofovir alafenamide	Tablet	Chemical Drugs(5.1)	License Renew	2023-01-28					view
JYHB2200118	恩曲他滨丙酚替诺福韦片(Ⅱ)	emtricitabine;tenofovir alafenamide	Tablet	Chemical Drugs	Supplementary Application	2022-03-09					view
JXHS2200057	恩曲他滨丙酚替诺福韦片(Ⅱ)	emtricitabine;tenofovir alafenamide	Tablet	Chemical Drugs(5.1)	Import Drug Application	2022-07-06					view
JYHB1900858	恩曲他滨丙酚替诺福韦片(Ⅱ)	emtricitabine;tenofovir alafenamide	Tablet	Chemical Drugs(5.1)	Supplementary Application	2019-07-12	吉利德（上海）医药科技有限公司	Gilead (Shanghai) Pharmaceutical Technology Co Ltd	Filed	2019-07-24	view
JYHB1901407	恩曲他滨丙酚替诺福韦片(Ⅱ)	emtricitabine;tenofovir alafenamide	Tablet	Chemical Drugs(5.1)	Supplementary Application	2019-11-28	吉利德（上海）医药科技有限公司	Gilead (Shanghai) Pharmaceutical Technology Co Ltd	Certificate Issued	2020-02-14	view